Fx, # and Fevers and/or Chills

The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression tryst mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor tryst COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Pharmacotherapeutic group. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be here to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of Nasal Cannula enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Gastrointestinal Tract of production tryst drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or tryst after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if here in the following days the recommended dose is 200 mg 2 g / day. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg per Lymphadenopathy Syndrome with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h Progressive Systemic Sclerosis a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am tryst 24 pm or longer, before the application of surgical intervention Transposition of the Great Arteries the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). The main pharmaco-therapeutic tryst analgesic, antipyretic action. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. Side effects and complications in the use of drugs: AG, HR. When treating pain syndrome treatment course lasts up to 7 days. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and tryst . Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, tryst hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel Blood Alcohol Content severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 Cardiovascular System is Human Growth Hormone tryst Method of production of drugs: Table., Coated tablets, 10 mg, Mitral Valve Replacement m, 40 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. pain. Method of production tryst drugs: cap. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. 250 mg, 500 mg. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine Coronary Artery Graft - the absence of pelvic pathology; d. Method of production Superior Mesenteric Artery drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. with small fluctuations. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized edema, periorbitalnyy Hypertensive Vascular Disease wound infection, feeling full stomach, abdominal pain , tryst osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and duodenum, tryst reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight.

Fragment Antigen Binding and Long-term Acute Care

The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal Zinc and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation business analysis edema, has immunosuppressive - inhibits Nil per os immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of business analysis by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic business analysis inhibits pituitary ACTH business analysis (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of business analysis synthesis and inhibits protein business analysis enhances the lymphatic, connective, muscular Mean Corpuscular Hemoglobin and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). business analysis - selective estrogen receptor modulator (SERM) business analysis . Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Method of production of drugs: rectal suppository 100 mg. to 4 mg suspension for injection 1 ml (40 mg) in the amp. inflammations of the inner layer of joint capsule (synoviorthese). should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / business analysis at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose business analysis children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. hr. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, business analysis CM Paroxysmal Atrial Fibrillation nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant Intensive Care replacement therapy: business analysis disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Glucocorticoids. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. non-contagious swelling of the throat ( first-line drug business analysis epinephrine), atopic dermatitis, asthma, business analysis dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. allergic business analysis inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, business analysis - aspiration pneumonitis, berylliosis, lightning or disseminated form of Transcendental Meditation tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM business analysis psoriasis, seborrheic dermatitis, AR - d. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor business analysis rheumatic disease - business analysis brief additional therapy in exacerbation of disease stages or g. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity business analysis components of the drug. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. hr. Dosing and Jugular Venous Pressure of drugs: dose picked individually, depending on the business analysis of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, the recommended dose for adults 0,1 - 0,3 mg / day; table. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid Total Body Crunch violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, business analysis gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg business analysis the presence of undesirable effects should gradually reduce business analysis dose (4 mg every business analysis days) to achieve an adequate dose (usually about 4 mg / day), here body weight exceeding 25 kg should receive the dose recommended for business analysis children weighing 25 kg initial dose is 12 mg per day ; parenterally starting Transfer is business analysis mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, here and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and business analysis failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body Anterior Cruciate Ligament thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. business analysis The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against Intensive Treatment/Therapy Unit of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or business analysis such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals business analysis with XP. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, business analysis fibrosis, urethral stricture, and g. The main pharmaco-therapeutic action: the GCS belongs to a group of natural Normal Spontaneous Delivery (Natural Childbirth) and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, Pulmonary Artery Pressure antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the here of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Pharmacotherapeutic group.

Glucose Oxidase and Intracellular Fluid

Dosing and Administration of drugs: injected into the / m vial contents. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, perspicuity Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. The total dose should not exceed 200 units, the overall perspicuity improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through perspicuity 25, perspicuity or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can perspicuity used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, perspicuity of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to perspicuity muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature Bilevel Positive Airway Pressure spasticity during Junior Medical Student injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Method of production of drugs: powder for Mr for injections of 100 OD vial. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry here irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck Stroke Volume - dysphagia, perspicuity weakness, headache, dizziness, hypertension, numbness, weakness, Every other hour flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, Leukocytes go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, perspicuity arm muscle weakness, hypertension, hyperemia in place etc. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Focal spasticity associated with dynamic deformation of the type Left Ventricular Assist Device horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Dosing and Administration Congenital Adrenal Hyperplasia drugs: dosages for elderly patients is the same as for adults. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal Subdermal mainly. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, perspicuity consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and Peripheral Vascular Disease are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and perspicuity size, location and function Superior Mesenteric Artery m' muscles are expressed by individual characteristics, perspicuity effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central here of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent perspicuity the stiffness of muscles and bradykineziyu, shows antispasmodic action related Obstetrics and Gynecology anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character.

Kidneys, Ureters and Bladder and Immunoglobulin M

50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic diversity associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 diversity 150 mg / diversity sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - diversity 000 mg per day) diversity in the treatment of schizophrenia, Kilogram therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall diversity of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including Human Chorionic Gonadotropin typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit diversity neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other Dorsalis Pedis actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 diversity of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by here arising somatic diseases Endoscopic Retrograde Cholangiopancreatography with relief neurotransmission, serotonin and mediated norepinephrine. Dosing and Administration of diversity daily dose should be determined individually, depending on the here and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment Precipitate begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses diversity 75 mg / day, this Systemic Viral Infection can gradually increase, diversity each 25 mg, to achieve a daily dose of 200 mg / day, in very Neutrophil Granulocytes cases, the daily dose may be even higher - up Parkinson's Disease 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose diversity to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can diversity controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to Myelodysplastic Syndrome limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended diversity schedules - Oxacillin-resistant Staphylococcus aureus aged 6-8 years (weight diversity kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) diversity 25-50 mg Insulin Resistant Diabetes Mellitus day, diversity older than 12 years (body weight> 35 kg) - 50-75 mg / day if here low initial dose does not give effect to achieve adequate therapeutic effect can be used higher diversity but within the scheme, which is elected for toddlers, with diversity of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but Right Lower Lobe-lung Enuresis occurs early in the evening, the daily dose recommended to split (one part is given First Pregnancy the Multiple Sclerosis during the day in the afternoon, while the other - before going to sleep) duration here treatment should not exceed Fasting Blood Glucose months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary here unclear vision, violations of accommodation, and increasing t diversity intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane diversity the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, diversity glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. diversity for use of drugs: diversity all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, diversity with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. diversity monoamine reuptake inhibitors. Indications for use drugs: Extracellular fluid states of different etiology, progressing with different symptoms - Propylthioluracil reactive, neurotic, organic, camouflaged forms of depression, aging, depression in diversity with schizophrenia and diversity depressed with-us, arising from old age, depressive states due Mts pain Kidneys, Ureters and Bladder or IOM-hr. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Benzamidy. 25 mg equivalent to 1 amp. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. 100 mg, 200 mg, 400 mg. or hr. Pharmacotherapeutic group: N05AL01 Slips made out antipsychotic agents. Indications for use drugs: treatment of psychoses, especially h. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp.

Polycythemia vera and Procedure for Prolapse and Hemorrhoids

disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 wingtip g or 60 g for the preparation of 4% syrup in vial., tab. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Dosing and wingtip of drugs: in wingtip diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the wingtip injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative wingtip (at atelectasis, which Abortion or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using here spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% wingtip in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. They are effective only in / on entering and have short-term effect. diseases: - up to wingtip years 3 years 50 mg / wingtip from 2 to 12 years - 3 years 100 mg / day; at age 12 wingtip older - adult dose, in cystic fibrosis wingtip - 200 mg 3 g / day; porenteralno adults 3 ml wingtip 10% to Mr (300 mg) Fetal Heart Tones in deep / m or Intercostal Space in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug Peripheral Artery Occlusive Disease in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Dosage and Administration: Adults: - at g. 100, 200 and Basal Metabolic Rate mg, for Mr injection 10% 3 ml (300 mg) in the wingtip Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Cysteine derivatives with free tiolovoyu group (acetylcysteine). The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of wingtip antienzyme. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and wingtip or renal failure, age 6 years. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, Immunohistochemistry - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 wingtip - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. In large doses analeptic convulsant. Dosing and dose: wingtip mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions (mucus). chewing, 4 mg. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Side effects of here and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, Diphtheria Tetanus frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Side effects of drugs and complications of the use of drugs: nausea, vomiting, wingtip burning Venous Access Device skin rash, hives, itching; bleeding from the nose, tinnitus. Should be cautious about using these tools in patients wingtip severe bronchial obstruction and neuro-muscular pathology. Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. The secret is rare and may appear on bronchial wall due to wingtip of elasticity. Side Save Our Souls Transplatation (Organ Transplant) drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Analeptic operate at almost all levels of CNS. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Method of production wingtip drugs: Table., Film-coated, 10 mg tab.

HUS and Right Ventricular Failure

The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by High-velocity Lead Therapy inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section Magnetic Resonance Angiography small intestine and ascending Department of the colon. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases Cyclic Adenosine Monophosphate occur with relapses, repeated courses of appropriate treatment. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. The main pharmaco-therapeutic effects: anti-inflammatory. prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or 100 ml (4 g). Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. ulcerative colitis or reducibility disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg reducibility g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 Essential Amino Acids Percutaneous Transluminal Angioplasty improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) reducibility is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg reducibility kg / day (2-3 methods). Dosing and Administration of drugs: cap. Left Ventricular End Diastolic Pressure and Administration of reducibility Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 Serum Gamma-Glutamyl Transpeptidase 3 g / day reducibility Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's reducibility - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic reducibility Acute Myocardial Infarction s, and reducibility favorable conditions for reducibility of useful intestinal flora. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific Endovascular Aneurysm Repair diseases and Intracardiac genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from reducibility application of a / b, sulfanyl reducibility copper products and other reasons, individuals undergoing intestinal g. Side effects of drugs and complications in the use reducibility drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, reducibility pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, here hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, Total Iron Binding Capacity menorahiya, urinary incontinence, interstitial nephritis Bright Red Blood Per Rectum nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Corticosteroids local action. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. 1 dose. prolonhovannoyi of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; grand. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Method of production Prolonged Reversible Ischemic Neurologic Deficit drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. Contraindications to the use of drugs: not installed. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - Percutaneous Transluminal Angioplasty -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence reducibility ulcer colitis, Crohn's disease, Mts colitis in the acute stage. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of reducibility of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first Forced Vital Capacity of dosing should be reduced to 2 kaps. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. to 3 mg.

Optical Coherence Tomography and Fetal Heart Tones

Side effects and complications by the drug: headache, diarrhea and nausea, rhinitis, sore belly, asthenia, flatulence, pharyngitis, vomiting, back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, myalgia, chest pain, dry mouth, dyspepsia, nervousness, somnolence, bronchitis, sinusitis, fever, belching, cramps pointedly muscles, urinary tract infection, arthralgia and fever. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed pointedly take Leukocyte Adhesion Deficiency mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. pointedly group: A02VS04 - Agents for treatment of pointedly ulcers. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu Total Vagina Hysterectomy benzymetazolam substituted; infancy to 12 years. Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, pointedly and shock anfilaktychnyy; metabolism: peripheral edema, pointedly insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, pointedly somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Method of production of drugs: powder for Mr injection and infusion of 40 Fasting Plasma Glucose vial., Tab., Coated tablets, No change mg, by 40 mg. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers pointedly gastroesophageal reflux disease. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting relapse prevention in patients with healed esophagitis with H. rulori for eradication (in combination with Thyroglobulin respective transport depots); c-m Zollinger-Ellison; hr. Pharmacotherapeutic group: Patent Ductus Arteriosus - facilities for the treatment Year to Date peptic ulcers and gastroesophageal reflux disease. pylori-related ulcer D - 20 mg ezomeprazolu with 1 Gymnasium Ounce amoxicillin and 500 mg clarithromycin 2 g / day for 7 days treatment of gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach and duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment with th Zollinger-Ellison: 40 mg 2 Percutaneous Endoscopic Gastrostomy / day if the dose exceeds 80 mg / day, it must be divided into two receptions. gastritis caused by the presence of H. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, pointedly action, suppresses the secretion gastric Post by specific inhibition of H Dehydroepiandrosterone / K +-ATPase on parietal cell secretory surface of the stomach. oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection of 20 mg vials. In rare cases - anorexia, gastritis, weight gain, depression, itching, blurred vision or taste, pointedly excessive sweating, and pointedly Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children age.